Dmitry Balyasny’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-30,000
Closed -$4.09M 1869
2020
Q3
$4.09M Buy
+30,000
New +$3.19M 0.03% 666
2018
Q2
Sell
-40,000
Closed -$1.95M 2308
2018
Q1
$1.95M Buy
+40,000
New +$2.08M 0.01% 1003

Dmitry Balyasny's MYOK Position: Q2 2020 in Review

Dmitry Balyasny sold out of MyoKardia, Inc. Common Stock (MYOK) in Q2 2020, closing a stake of 12,843 shares — an estimated $602K sold.

Dmitry Balyasny first reported a position in MYOK in Q1 2019 and held it in 2 quarters. The position peaked at $829K in Q1 2019. 235 funds tracked by Wall St. Rank hold MYOK as of Q2 2020.

  • Dmitry Balyasny reported no remaining MyoKardia, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
  • Dmitry Balyasny sold 12,843 MyoKardia, Inc. Common Stock shares in Q2 2020, an estimated $602K.
  • Dmitry Balyasny first reported a position in MyoKardia, Inc. Common Stock in Q1 2019 and held it in 2 quarters.
  • Dmitry Balyasny's MyoKardia, Inc. Common Stock position peaked at $829K in Q1 2019.
  • 235 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q2 2020.

Based on Balyasny Asset Management's 13F filing for Q2 2020, filed 14 Aug 2020.